Immunovant Inc. (IMVT)
Market Closed
20 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
39. 92
-0.34
-0.8445%
$
7.96B Market Cap
- P/E Ratio
- Div Yield
721,492 Volume
-1.77 Eps
$ 40.26
Previous Close 
Want to track IMVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immunovant Inc. (IMVT) Statistics
Valuation metrics
Market Cap 7.96B
Enterprise value 7.36B
Trailing P/E (ttm) -14.48
Forward P/E -
PEG ratio 7.3
Price/Sales (ttm) -
Price/Book (mrq) 9.62
Enterprise Value/Revenue -
Enterprise Value/EBITDA -14.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 753.37K
Average volume (90 days) 2.1M
Price summary
52-Week low 14.32
52-Week high 41.23
Beta -
50-Day moving average 36.72
200-Day moving average 27.27
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.53%
Return on equity -0.68%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 9.09%
Book value per share (mrq) 4.19
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
